Evidence map›Paper›PMID 30648648›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2019

Redox regulation of hormone sensitive lipase: Potential role in the mechanism of MEHP-induced stimulation of basal steroid synthesis in MA-10 Leydig cells.

Christine Zhou, Ninad Zaman, Yunbo Li, Daniel B Martinez-Arguelles, Vassilios Papadopoulos, Barry Zirkin, Kassim Traore

Open access · greenAbstract read
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Frontiers in toxicology · 2025
    Article
  3. Use ofFrontiers in toxicology · 2024
    Article
  4. Article
  5. 10Frontiers in cell and developmental biology · 2022
    Article
  6. Article
  7. Redox Regulation of Lipid Mobilization in Adipose Tissues.Antioxidants (Basel, Switzerland) · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Christine ZhouDepartment of Biochemistry and Genetics, Campbell University Jerry M. Wallace School of Osteopathic Medicine, Lillington, NC 27546, USA.
Ninad ZamanDepartment of Biochemistry and Genetics, Campbell University Jerry M. Wallace School of Osteopathic Medicine, Lillington, NC 27546, USA.
Yunbo LiDepartment of Pharmacology, Campbell University Jerry M. Wallace School of Osteopathic Medicine, Lillington, NC 27546, USA.
Daniel B Martinez-ArguellesResearch Institute of the McGill University Health Centre and Department of Medicine, McGill University, Montreal, Quebec H4A 3J1, Canada.
Vassilios PapadopoulosDeparment of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90089, USA.
Barry ZirkinDepartment of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.
Kassim TraoreDepartment of Biochemistry and Genetics, Campbell University Jerry M. Wallace School of Osteopathic Medicine, Lillington, NC 27546, USA. Electronic address: ktraore@campbell.edu.
Campbell University · USJohns Hopkins University · USMcGill University Health Centre · CAUniversity of Southern California · US

Funding

AGING AND LEYDIG CELL FUNCTIONR01AG021092 · NIA · JOHNS HOPKINS UNIVERSITY · PI ZIRKIN, BARRY R · 2002 to 2019
$3.1M
Title: In Vitro Analysis of the Effects of Acute and Chronic Phthalate Exposures on Leydig Cell Testosterone Production, and the Molecular Mechanisms InvolvedR15ES032102 · NIEHS · DUQUESNE UNIVERSITY · PI TRAORE, KASSIM · 2020 to 2023
$871k
AGE-RELATED ALTERATION OF LEYDIG CELL REDOX ENVIRONMENT A RISK FACTOR FOR SUSCEPTSC2GM099578 · NIGMS · ELIZABETH CITY STATE UNIVERSITY · PI TRAORE, KASSIM · 2012 to 2014
$383k
NIA NIH HHS R01 AG021092NIEHS NIH HHS R15 ES032102NIGMS NIH HHS SC2 GM099578
6 · The paper itself

Abstract

Mono-(2-ethylhexyl) phthalate (MEHP), the active metabolite of di-(2-ethylhexyl) phthalate (DEHP), is a plasticizer with endocrine disruptor activity that has been shown to stimulate basal steroid biosynthesis in Leydig cells. The mechanism by which it does so is unknown. Using MA-10 mouse tumor Leydig cells, we assessed the effects of MEHP on reactive oxygen species (ROS) levels, and on the signal transduction pathways that mobilize cholesterol. Exposure to 0-300 μM MEHP stimulated basal progesterone production in a dose-dependent manner. Progesterone stimulation was correlated with increases in the phosphorylation of hormone-sensitive lipase (HSL; aka cholesteryl ester hydrolase), which is involved in the production of free cholesterol, and of steroidogenic acute regulatory (STAR) protein expression. Co-treating MA-10 cells with MEHP and the ROS scavenger N-acetyl cysteine (NAC) blocked the activation of HSL, blunted MEHP-induced STAR, and reduced basal progesterone formation. These observations suggest that ROS generation by MEHP leads to activation of HSL and increase in STAR which, together, result in increased free-cholesterol bioavailability and progesterone formation.

Indexed as

AcetylcysteineAnimalsCell Line, TumorCholesterolDiethylhexyl PhthalateEndocrine DisruptorsLeydig CellsMaleMiceOxidation-ReductionPhosphoproteinsPlasticizersProgesteroneReactive Oxygen SpeciesSteroidogenic Acute Regulatory ProteinSterol EsteraseAcetylcysteineCholesterolDiethylhexyl PhthalateEndocrine Disruptorsmono-(2-ethylhexyl)phthalatePhosphoproteinsPlasticizersProgesteroneReactive Oxygen SpeciesSteroidogenic Acute Regulatory ProteinSterol EsteraseAntioxidantsPhthalatesROS

Identifiers

PMID30648648
PMCPMC11472792
OpenAlexW2908607574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.